PROCEPT BioRobotics Corporation

NASDAQ:PRCT

82.79 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 53.35344.53943.58135.10233.10424.40423.77720.34916.69114.19710.1388.6688.4767.1923.2212.1071.1951.195
Cost of Revenue 23.1419.50523.64416.22814.67511.91313.10110.1188.2056.5055.6224.4284.8933.6652.7512.1382.0412.041
Gross Profit 30.21325.03419.93718.87418.42912.49110.67610.2318.4867.6924.5164.243.5833.5270.47-0.031-0.847-0.847
Gross Profit Ratio 0.5660.5620.4570.5380.5570.5120.4490.5030.5080.5420.4450.4890.4230.490.146-0.015-0.709-0.709
Reseach & Development Expenses 16.23213.08413.17811.611.61310.7379.6827.5826.7065.0115.0764.9194.4764.5224.5433.8933.923.92
General & Administrative Expenses 000000000000000000
Selling & Marketing Expenses 000000000000000000
SG&A 40.80939.59936.31632.88332.44130.13126.03424.75419.65518.38516.27112.11812.29910.3499.1347.0547.0427.042
Other Expenses 000000000-0.059-0.067-0.052-0.027-0.009-0.0160.01800
Operating Expenses 57.04152.68349.49444.48344.05440.86835.71632.33626.36123.39621.34717.03716.77514.87113.67710.94711.03711.037
Operating Income -26.828-27.649-29.557-25.609-25.625-28.377-25.04-22.105-17.875-15.704-16.831-12.797-13.192-11.344-13.207-10.978-11.808-11.808
Operating Income Ratio -0.503-0.621-0.678-0.73-0.774-1.163-1.053-1.086-1.071-1.106-1.66-1.476-1.556-1.577-4.1-5.21-9.885-9.885
Total Other Income Expenses Net 1.2021.6922.0530.9870.34-0.107-3.132-0.508-1.309-1.481-0.1040.1410.035-0.028-0.3230.334-1.058-1.058
Income Before Tax -25.626-25.957-27.504-24.622-25.285-28.484-28.172-22.613-19.184-17.185-18.348-14.103-14.58-12.822-15.278-12.008-12.866-12.866
Income Before Tax Ratio -0.48-0.583-0.631-0.701-0.764-1.167-1.185-1.111-1.149-1.21-1.81-1.627-1.72-1.783-4.743-5.699-10.771-10.771
Income Tax Expense 01.1411.833-1.0541.183-0.7793.1320.5081.3091.481-8.6660.8141.4711.4551.7551.40500
Net Income -25.626-25.957-27.504-24.622-25.285-27.705-31.304-23.121-20.493-18.666-18.348-14.103-14.58-12.822-15.278-12.008-12.866-12.866
Net Income Ratio -0.48-0.583-0.631-0.701-0.764-1.135-1.317-1.136-1.228-1.315-1.81-1.627-1.72-1.783-4.743-5.699-10.771-10.771
EPS -0.5-0.51-0.54-0.51-0.56-0.61-0.7-0.52-0.46-0.43-0.42-1.22-0.35-0.36-0.43-0.34-4.56-4.56
EPS Diluted -0.5-0.51-0.54-0.51-0.56-0.61-0.7-0.52-0.46-0.43-0.42-1.22-0.35-0.36-0.43-0.34-4.56-4.56
EBITDA -25.559-26.465-28.239-25.609-24.32-27.598-24.048-20.455-17.026-14.969-16.831-12.634-12.294-10.424-12.485-10.222-11.093-11.093
EBITDA Ratio -0.479-0.594-0.648-0.73-0.735-1.131-1.011-1.005-1.02-1.054-1.66-1.458-1.45-1.449-3.876-4.851-9.287-9.287